About Us
Group Profile
Introduction
Mission
History
Honor
Brand Interpretation
Vision
Development
Party Affairs
Material Download
Innovation
Biologics
Small Molecule(s)
Innovative Technology
Ongoing Projects
R & D Team
Capabilities
Core Competence
Platform Enterprise
Management System
Products
Rx
Renal
Oncology
Cardiovascular
Respiratory
Pain
OTC
News
Company Release
Media Coverage
Information Disclosure
Adverse Drug Reaction Reporting Platform
Public Notice of Pharmaceutical Representative Record (Third Party Website)
Product Traceability
Enterprise Announcement
CSR
Responsibility Bearng
Social Welfare
CSR Report
Talents
Talent Management
Enterprise University
Join Us
medicine
medicine
Clean energy
Investment
EN
/
CN
Medicine
Medicine
Clean energy
Investment
Renal
首页
Renal
森能-盐酸西那卡塞片
国药准字:H20213111基药:是医保:国家医保目录乙类品种适应症:本品用于治疗慢性肾脏病(CKD)维持性透析患者的继发性甲状旁腺功能亢进症。简介:2021年 2 月 2 日获批,后进入第五批国家带量采购,将带来更高的性价比,在为更多患者带来生存获益的同时,也将显著降低患者家庭及社会的经济负担。
Related literature
Related Consensus